Clinical trial
Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life
NCT07257861 is registered in ClinicalTrials.gov with Centre Hospitalier Régional d'Orléans as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life
- Lead sponsor
- Centre Hospitalier Régional d'Orléans
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 2, 2026
- Completion date
- February 28, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.